Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Wilson º´ÀÇ Áø´Ü½Ã ÀÓ»ó ¹ßÇö ¾ç»ó¿¡ ´ëÇÑ °íÂû The Study of the Initial Presentations of Wilson Disease at Diagonosis

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2001³â 4±Ç 2È£ p.199 ~ 206
¾çÅÂÁø, Áö±ÙÇÏ, ¼Û¹Î¼·, ȲűÔ,
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÅÂÁø ( Yang Tae-Jin ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¼Ò¾Æ°úÇб³½Ç

Áö±ÙÇÏ ( Chi Geun-Ha ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¼Ò¾Æ°úÇб³½Ç
¼Û¹Î¼· ( Song Min-Seob ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¼Ò¾Æ°úÇб³½Ç
ȲűԠ( Hwang Tae-Guy ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñÀû: Àª½¼º´À¸·Î Áø´Ü ¹ÞÀº ȯÀÚµéÀÇ Áø´Ü ´ç½ÃÀÇ ÀÓ»ó ¾ç»óÀÇ ºÐÆ÷, ¹ßº´ ¿¬·É°ú °Ë»ç ¼Ò°ßµéÀ» ÆľÇÇÏ°í, ¶ÇÇÑ Ãʱ⠹߰ßÀÇ Á߿伺À» °íÂûÇÏ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ¹ý: 1990³â 1¿ùºÎÅÍ 10³â°£ ºÎ»ê ¹éº´¿ø¿¡ ÀÔ¿øÇÏ¿© Àª½¼º´À¸·Î Áø´Ü ¹ÞÀº ȯÀÚ 20·Ê¸¦ ´ë»óÀ¸·Î Áø´Ü ´ç½ÃÀÇ Áõ»ó°ú Áõ»ó ¹ßÇö½Ã±â, Áø´Ü±îÁöÀÇ ±â°£, °Ë»ç ¼Ò°ß µîÀ» ÈÄÇâÀûÀ¸·Î Á¶»çÇÏ¿´´Ù.

°á°ú: 20¸íÀÇ È¯ÀÚµé Áß¿¡ °£ Áõ»ó ´Üµ¶ ¹ßÇöÀº 12¸í(60%), ±× Áß 2¸íÀº ¿ì¿¬È÷ AST/ALT°¡ Áõ°¡µÈ °ÍÀ» ¹ß°ßÇÑ °æ¿ì¿´À¸¸ç, ½Å°æ Áõ»ó ´Üµ¶ ¹ßÇöÀº 2¸í(10%), ½Å°æ Á¤½ÅÁõ»ó°ú °£ Áõ»óÀÌ °°ÀÌ ³ªÅ¸³­ °æ¿ì´Â 4¸í(20%), Ç÷¾× Áõ»óÀÌ ÁÖµÈ °æ¿ì 1¸í(5%), ±×¸®°í Áõ»óÀÌ ¾øÀ¸¸ç AST/ALTµµ Á¤»óÀ̳ª °¡Á· °ËÁø¿¡¼­ Ç÷Áß ceruloplasminÀÌ °¨¼ÒµÈ °ÍÀ» ¹ß°ßÇÑ °æ¿ì°¡ 1¸í(5%) ÀÖ¾ú´Ù. ¸ðµç ȯÀڵ鿡°Ô¼­ Ç÷Áß ceruloplasminÀÇ ³óµµ´Â À¯ÀÇÇÏ°Ô ³·¾Ò´Ù. °¡Á··ÂÀº 5·Ê¿¡¼­ ÀÖ¾ú´Ù. °£ Áõ»óÀº Áø´Ü½Ã ÀÌ¹Ì °£°æÈ­·Î ÁøÇàÇÑ °ÍÀ» ÃÊÀ½ÆÄ·Î Áø´ÜÇÑ °æ¿ì°¡ 12¸í(60%)À̾úÀ¸¸ç, ÀÌ Áß 2¸íÀÌ Áø´Ü ÈÄ 1³â ³»¿¡ »ç¸ÁÇÏ¿´´Ù.

°á·Ð: Àª½¼º´Àº ºü¸¥ Áø´Ü°ú Ä¡·á°¡ Áß¿äÇÏ´Ù. ±×·¯³ª ´Ù¸¥ À¯Àü¼º ´ë»çÁúȯµé°ú´Â ´Þ¸® Àüü ½Å»ý¾ÆÀÇ ¼±º°°Ë»ç´Â Àǹ̰¡ ¾øÀ¸¸ç, ȯÀÚ°¡ ÀÖ´Â °¡Á·¿¡¼­ Ç÷Áß ceruloplasmin°ú ¼Òº¯ ³» ±¸¸®, °£ È¿¼Ò ¼öÄ¡¿Í °¢¸·À» °Ë»çÇÏ´Â °ÍÀÌ ÁÁ´Ù. ¼Ò¾Æ±â¿¡ °£¿°ÀÇ Áõ»óÀ̳ª Áö¼ÓÀûÀ¸·Î Áõ°¡µÈ °£ È¿¼Ò ¼öÄ¡¸¦ º¸ÀÏ ¶§ ¶Ç´Â °¡Á· Áß¿¡ ¿øÀÎÀÌ ¹àÇôÁöÁö ¾ÊÀº °£ ÁúȯÀÇ °¡Á··ÂÀÌ ÀÖÀ» ¶§¿¡´Â Àª½¼º´À» ÀǽÉÇØ º¸¾Æ¾ß ÇÏ°Ú´Ù. ¶ÇÇÑ Ã»¼Ò³â±â ÀÌÈÄ¿¡ Ãßü¿Ü·Î Áõ»óÀ̳ª ¼Ò³ú Áõ»ó µî ¿îµ¿ ½Å°æ°èÀÇ Áõ»óÀ» È£¼ÒÇϵçÁö Ç÷¾× ÀÌ»ó, ¼Òº¯ °Ë»ç»ó ÀÌ»óÀÌ º¹ÇÕÀûÀ¸·Î ³ªÅ¸³ª´Â °æ¿ì µî¿¡¼­µµ Ç÷Áß ceruloplasminÀ» ²À È®ÀÎÇØ º¸¾Æ¾ß ÇÑ´Ù. ±× ¿Ü¿¡ ½Å°æ Áõ»ó ¹× Á¤½Å Áõ»óÀ» ÁÖ¼Ò·Î ³»¿øÇÑ °æ¿ì¿¡µµ °£±â´É °Ë»ç¸¦ ²À ½ÃÇàÇØ º¸¾Æ¾ß ÇÏ°Ú´Ù.

Purpose: To review the clinical and laboratory features of patients with Wilson disease at diagnosis.
Methods: In this retrospective study, records of all 20 patients, who were diagnosed as having Wilson disease at the Paik hospital in Busan from 1990 to 2000, were reviewed.

Results: Out of 20 patients, 12 pateints (60%) have hepatic presentation alone, 2 patients (10%) have neurologic presentation, 4 patients (20%) have hepatic and neuropsychiatric presentation, and one patient (5%) has hematologic presentation at diagnosis. One patient (5%) has neither symptom nor laboratory finding of Wilson disease except very low serum ceruloplasmin level and positive family history. Family screening test revealed 3 cases of Wilson disease. 12 patients were revealed to be combined with liver cirrhosis at diagnosis.

Conclusion: Early diagnosis and treatment is very important in patients with Wilson disease. Children or adolescents who manifest symptoms of hepatitis, who has prolonged elevation of liver enzymes, and has family history of hapatitis of unknown origin, with mild hematologic or urinary abnormalities must be suspected to have Wilson disease. Also, in adolescents with extrapyramidal symptoms or other neuropsychiatric symptoms, liver function test should be done.

Å°¿öµå

Wilson disease;Diagnosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS